Adastria Co., Ltd. (TYO:2685)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions JPY. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2025	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Market Capitalization	142,221	134,298	154,402	98,275	76,831	90,141
Market Cap Growth	-21.36%	-13.02%	57.11%	27.91%	-14.77%	9.31%
Enterprise Value	129,774	119,723	139,873	89,820	66,915	70,919
Last Close Price	3085.00	2901.00	3314.88	2052.07	1562.56	1778.40
PE Ratio	14.89	13.97	11.43	13.03	15.63	-
Forward PE	11.37	10.13	11.92	11.38	14.79	22.50
PS Ratio	0.48	0.46	0.56	0.41	0.38	0.49
PB Ratio	1.82	1.74	2.16	1.62	1.40	1.78
P/TBV Ratio	2.30	2.15	2.67	2.07	1.76	2.08
P/FCF Ratio	-	9.70	9.33	15.19	-	11.09
P/OCF Ratio	-	6.28	6.95	7.30	21.93	7.55
PEG Ratio	-	0.59	0.59	0.59	0.59	0.59
EV/Sales Ratio	0.44	0.41	0.51	0.37	0.33	0.39
EV/EBITDA Ratio	4.83	4.43	4.94	4.37	4.80	8.78
EV/EBIT Ratio	8.59	7.72	7.76	7.80	9.80	92.34
EV/FCF Ratio	-	8.64	8.45	13.88	-	8.73
Debt / Equity Ratio	0.14	0.12	0.13	0.14	0.09	0.07
Debt / EBITDA Ratio	0.40	0.33	0.32	0.40	0.36	0.45
Debt / FCF Ratio	-	0.65	0.54	1.26	-	0.45
Asset Turnover	2.13	2.25	2.30	2.32	2.09	1.90
Inventory Turnover	4.71	4.75	4.78	5.00	5.18	5.45
Quick Ratio	0.75	0.76	0.81	0.65	0.70	0.83
Current Ratio	1.29	1.43	1.42	1.27	1.25	1.26
Return on Equity (ROE)	12.55%	12.73%	20.46%	13.44%	9.31%	-1.29%
Return on Assets (ROA)	6.79%	7.43%	9.41%	6.88%	4.41%	0.50%
Return on Capital (ROIC)	11.48%	11.63%	15.07%	11.17%	7.47%	0.84%
Return on Capital Employed (ROCE)	17.50%	18.00%	22.70%	17.10%	11.50%	1.40%
Earnings Yield	6.74%	7.16%	8.75%	7.67%	6.40%	-0.77%
FCF Yield	-	10.31%	10.72%	6.59%	-0.38%	9.01%
Dividend Yield	2.97%	3.10%	2.56%	2.92%	3.52%	2.25%
Payout Ratio	-	40.74%	23.64%	33.29%	46.43%	-
Buyback Yield / Dilution	-1.94%	-1.40%	-0.14%	-0.21%	2.94%	1.08%
Total Shareholder Return	1.03%	1.71%	2.43%	2.72%	6.46%	3.33%

Updated Dec 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.